1 Green Flag That's Also a Red Flag for Pfizer Stock

This is a bit of a trying time for Pfizer (NYSE: PFE). While the last 12 months saw the stock market provide a stunning total return of 41%, the struggling pharmaceutical giant returned a piddling 1%.Raining on the parade even more, Pfizer just reported some good news that seems to confirm the presence of some internal issues. So let's examine this new green flag that's also a red flag for anyone looking to buy the stock.On Oct. 29, Pfizer reported its third-quarter earnings. Though the consensus estimate for its earnings per share (EPS) from Wall Street analysts was $0.62, its diluted EPS was actually higher than anticipated, at $0.78. Similarly, it also announced that it was hiking its annual guidance for adjusted diluted EPS from $2.45 at the upper end to a maximum of $2.65, and hiking guidance for revenue from a peak of $62.5 billion to an upper bound of $64 billion.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool